|
Companies |
Month |
Amount |
|
AVEO Pharmaceuticals/Astellas |
February |
$1.425B |
|
Evotec AG/Roche AG |
September |
$830M |
|
Rib-X Pharmaceuticals/Sanofi SA |
July |
$763M |
|
Intra-Cellular Therapies/Takeda |
March |
$750M |
|
F-Star GmbH/Merck Serono |
September |
$691M |
|
Epizyme/GlaxoSmithKline |
January |
$650M |
|
Theraclone Sciences/Pfizer |
January |
$632M |
|
Santaris Pharma/Pfizer |
January |
$614M |
|
Glenmark Pharma/Sanofi-Aventis |
May |
$613M |
|
Astellas Pharma/Royalty Pharma |
July |
$609M |
